Guelph, Canada

Krishnaraj Tiwari

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Her Majesty the Queen in Right of Canada, as Represented by the Minister of National Defence. Active years: 2022.


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Krishnaraj Tiwari: Innovator in Antibody Production

Introduction

Krishnaraj Tiwari is a notable inventor based in Guelph, Canada. He has made significant contributions to the field of biotechnology, particularly in the production of antibodies in plants. His innovative approach has the potential to impact therapeutic and prophylactic applications.

Latest Patents

Tiwari holds a patent for a method of producing ricin antibodies that bind to the ricin B chain. This patent describes a process that involves introducing nucleic acid molecules encoding the heavy and light chain variable regions of the antibody into a plant or plant cell. The method culminates in growing the plant or plant cell to obtain a plant that expresses the antibody or antibody fragment. This advancement not only relates to the antibodies themselves but also to their applications in therapy and prophylaxis.

Career Highlights

Krishnaraj Tiwari is associated with Her Majesty the Queen in Right of Canada, as Represented by the Minister of National Defence. His work in this capacity has allowed him to explore innovative solutions in the field of biotechnology. Tiwari's dedication to research and development has positioned him as a key figure in his area of expertise.

Collaborations

Some of Tiwari's notable coworkers include J. Christopher Hall and Ashley J. Meyers. Their collaborative efforts contribute to the advancement of research in antibody production and related fields.

Conclusion

Krishnaraj Tiwari's work in the production of ricin antibodies represents a significant advancement in biotechnology. His innovative methods and dedication to research continue to pave the way for future developments in therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…